Indian regulators halt Sun Pharma eye drug production in Assam
By United One News · AI-generated summary of 3 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
- Indian regulators ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at its Assam facility.
- The regulatory action followed the discovery of failures in the company.
Covered by 3 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
CDSCO drug alert: Himachal pulls 92 substandard batches, halts 96 pharma units
Timeline
First to report: Mint (); 3 articles from 3 outlets so far.
Who is covering this story
- Center (3): Mint, Economic Times, Business Today
Sources
- CDSCO drug alert: Himachal pulls 92 substandard batches, halts 96 pharma units — Mint (center) ·
- Sun Pharma's eye drug production hits a roadblock — Economic Times (center) ·
- Regulator orders Sun Pharma to shut Assam plant over eye-drop quality lapses; what you should know — Business Today (center) ·